skip to Global Navigation Bar skip to main content


homeHome > R&D > Global R&D

 Global R&D

Daewoong is actively pursuing globalization through worldwide R&D activities in Korea, China, India and the USA.
Daewoong Life Science Research Institute is focused on developing new chemical entities, biologics and incrementally modified drugs, etc. India R&D Center is a base camp for launching global products, developing new formulation
technologies and global clinical studies. China R&D Center seeks to license in new formulation technologies and botanical medicines unique to China. Daewoong America Inc is strategically focused on introducing value added, competitive products to the US market.